GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » United Health Products Inc (OTCPK:UEEC) » Definitions » ROIC %

UEEC (United Health Products) ROIC % : -173.45% (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is United Health Products ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. United Health Products's annualized return on invested capital (ROIC %) for the quarter that ended in Sep. 2024 was -173.45%.

As of today (2024-12-15), United Health Products's WACC % is 6.53%. United Health Products's ROIC % is -187.74% (calculated using TTM income statement data). United Health Products earns returns that do not match up to its cost of capital. It will destroy value as it grows.


United Health Products ROIC % Historical Data

The historical data trend for United Health Products's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Health Products ROIC % Chart

United Health Products Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,770.00 -2,891.72 -6,772.95 -472.51 -264.38

United Health Products Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -188.09 -199.11 -198.83 -193.43 -173.45

Competitive Comparison of United Health Products's ROIC %

For the Medical Instruments & Supplies subindustry, United Health Products's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Health Products's ROIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, United Health Products's ROIC % distribution charts can be found below:

* The bar in red indicates where United Health Products's ROIC % falls into.



United Health Products ROIC % Calculation

United Health Products's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROIC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=-2.427 * ( 1 - 0% )/( (0.967 + 0.869)/ 2 )
=-2.427/0.918
=-264.38 %

where

United Health Products's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Sep. 2024 is calculated as:

ROIC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=-1.568 * ( 1 - 0% )/( (0.834 + 0.974)/ 2 )
=-1.568/0.904
=-173.45 %

where

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


United Health Products  (OTCPK:UEEC) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, United Health Products's WACC % is 6.53%. United Health Products's ROIC % is -187.74% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


United Health Products ROIC % Related Terms

Thank you for viewing the detailed overview of United Health Products's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


United Health Products Business Description

Traded in Other Exchanges
N/A
Address
520 Fellowship Road, Suite No D-406, Mt. Laurel, NJ, USA, 08054
United Health Products Inc is a United States-based company. It mainly manufactures and markets a patented hemostatic gauze for the healthcare and wound care sectors. The company's product HemoStyp is derived from regenerated oxidized cellulose, which is naturally designed to absorb exudate from superficial wounds and helps control bleeding. It markets its product to dental and medical markets as well as, sports, military and veterinary sectors, and others. The company's trademarks include Boo Boo Strips; The Ultimate Bandage; Hemostrips; CelluSTAT and Nik Fix.
Executives
Brian David Thom officer: CEO 10624 S EASTERN AVE., STE A209, HENDERSON NV 89052
Kristofer Heaton officer: Vice-President Finance, CFO 526 COMMERCE CIRCLE, STE 120, MESQUITE NV 89027
Nate Knight director C/O MORSE & MORSE, PLLC, 1400 OLD COUNTRY ROAD, SUITE 302, WESTBURY NY 11590
Louis Schiliro officer: Chief Operating Officer 10624 S. EASTERN AVENUE, STE. A209, HENDERSON NV 89052
Douglas K Beplate officer: CEO
Robert J. Denser director 10624 S. EASTERN AVE., STE. A209, HENDERSON NV 89052
John Vito Capotorto director 1090 KING GEORGES POST ROAD, SUITE 501, EDISON NJ 08837
Sherman Lazrus director
Rodney Paul Leibowitz director 420 EAST 54TH STREET, APARTMENT 15B, NEW YORK NY 10022
Michael R. Wiechnik director 11 PRESWICK DR., MEDFORD NJ 08055
Richard Rifenburgh director 2637 E. ATLANTIC BLVD., #133, POMPANO BEACH FL 33062
Phillip David Forman director, officer: President, Chairman and CEO 1090 KING GEORGES POST RD,501, EDISON NJ 08837
Jan E Chason director, officer: Chief Financial Officer 120 WALL STREET, SUITE 2401, NEW YORK NY 10005
Kelly Thomas Hickel director, officer: Chief Executive Officer 1630A 30TH STREET, SUITE 300, BOULDER CO 80301
Patrick Donelan 10 percent owner 3570 LAKEVIEW DRIVE, DELRAY BEACH FL 33445